Company
Opsona
- Status
- Shut downas of 2026-09-17Source (opens in a new tab)
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Targeting the human immune system, Opsona developed drugs with wide applicability to conditions such as autoimmune and inflammatory diseases, solid organ transplantation and oncology. The company ceased operations in 2019.
About the company
- Status notes
- The company ceased operations in 2019.
Loading relationship preview